Clinical Professor, Oncology, Perelman School of Medicine at the University of Pennsylvania
Hematology
Dr. David M. Mintzer, MD
|
|
Give Review
David M. Mintzer, MD is an expert in the field of Hematology. He graduated from Jefferson Medical College. He has 5 awards "America's Top Doctors", "Philadelphia Magazine", "America's Top Doctors for Cancer", "Super Doctor" and "Top MD". David M. Mintzer, MD has written publications. He has 37 publications published with PubMed. The lastest publication is: 'A phase II study of 5-fluorouracil, leucovorin, adriamycin, and cisplatin (FLAP) for metastatic gastric and gastroesophageal junction adenocarcinoma. A Penn Cancer Cli...' He is registered with Medicare.
Publications
- BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/Leukemia, a potential mimic of hairy cell Leukemia.
- Phase II Multicenter Trial of Albumin-Bound Paclitaxel and Capecitabine in First-Line Treatment of Patients With Metastatic Breast Cancer.
- Esthesioneuroblastoma (Olfactory Neuroblastoma) with Ectopic ACTH Syndrome: a multidisciplinary case presentation from the Joan Karnell Cancer center of Pennsylvania H...
- Promising survival in patients with recurrent non-small cell lung Cancer treated with docetaxel and gemcitabine in combination as second-line therapy.
- Treating one of our own.
- On how increasing numbers of newer Cancer therapies further delay referral to hospice: the increasing palliative care imperative.
- Chemotherapy-induced amenorrhea from adjuvant breast Cancer treatment: the effect of the addition of taxanes.
- On the deluge of unsubscribed medical oncology information.
- Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.
- Cancer of unknown primary: changing approaches. A multidisciplinary case presentation from the Joan Karnell Cancer center of pennsylvania hospital.
- On the need for biopsy confirmation at suspected first recurrence of Cancer.
- Drug-induced hematologic Syndromes.
- Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung Cancer: a phase II trial.
- Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
- Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access program.
- Digital gangrene following chemotherapy for AIDS-related Kaposi's Sarcoma.
- Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency Syndrome.
- Phase II trial of mitomycin in malignant mesothelioma.
- Phase II trial of high-dose cisplatin in patients with malignant mesothelioma.
- Lymphosarcoma cell Leukemia and other non-Hodgkin's lymphomas in leukemic phase.
- Progression of nodular poorly differentiated lymphocytic Lymphoma to Burkitt's-like Lymphoma.
- Bringing an inpatient palliative care program to a teaching hospital: lessons in leadership.
- Breast Cancer in the very young patient: a multidisciplinary case presentation.
- Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung Cancer (NSCLC): results of OPN-017.
- Malignant mesothelioma following radiation therapy.
- An interdisciplinary approach to manage Cancer cachexia.
- A phase II study of 5-fluorouracil, leucovorin, adriamycin, and cisplatin (FLAP) for metastatic gastric and gastroesophageal junction adenocarcinoma. A Penn Cancer Cli...
- Clinical Syndromes of transformation in clonal hematologic disorders.
- Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of Anemia in AIDS.
- High-dose human lymphoblastoid interferon in metastatic colorectal Cancer: clinical results and modification of biological responses.
- Phase II study of human lymphoblastoid interferon in patients with multiple myeloma.
- Peripheral T-cell lymphoma in a patient with the acquired immunodeficiency Syndrome.
- Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: inDuction of inflammatory responses at tumor sites.
- The changing role of surgery in the diagnosis and treatment of Cancer.
- Triggering of myocardial infarction by cocaine.
- Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.
Schools
Jefferson Medical College Of Thomas Jefferson University Thomas Jefferson University
Pennsylvania Hospital
Jefferson Med College
Meml Sloan Kettering Med Ct
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Philadelphia Magazine
- America's Top Doctors for Cancer
- Super Doctor
- Top MD
Education
-
Memorial Sloan-Kettering Cancer Center -
Pennsylvania Hospital - University of Pennsylvania Health System -
Jefferson Medical College
Hospital
-
Hospital of the University of Pennsylvania -
Pennsylvania Hospital
Drug Facts
| NPI NUMBER | 1487648846 | |
| NPPES Provider LastName | MINTZER | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 191063500 | |
| NPPES Provider State | PA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1321.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 81.0 | |
| Percent Opioid Claims | 6.13 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1487648846 |
| Last Name Of The Provider | MINTZER |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Ingrid F. Kohut, DO
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David H. Henry III, MD |
|
|
Dr. Bernard A. Mason, MD |
|
|
Dr. Lee P. Hartner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arthur P. Staddon, MD
This Doctor is OpenDoctor Recommended.
|